Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Italian journal of gastroenterology and hepatology

• Publication date

  1999-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 10363198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay

  1997cited by this paper
• Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

  1997cited by this paper
• Treatment of chronic hepatitis C with interferon alfa‐n3: A multicenter, randomized, open‐label trial

  1997cited by this paper
• Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.

  1997cited by this paper
• Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

  1997cited by this paper
• Treatment of chronic hepatitis C with amantadine.

  1997cited by this paper
• Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

  1996cited by this paper
• Response to higher doses of interferon alfa‐2b in patients with chronic hepatitis C: A randomized multicenter trial

  1996cited by this paper
• Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays

  1996cited by this paper
• Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group.

  1995cited by this paper
• Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.

  1995cited by this paper
• Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C

  1995cited by this paper
• Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.

  1995cited by this paper
• Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management

  1995cited by this paper
• A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

  1994cited by this paper
• Amantadine for influenza A.

  1991cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

  1989cited by this paper

• Evidence based management of hepatitis

  2014cites this paper
• Aminoadamantanes for chronic hepatitis C.

  2014cites this paper
• Study of the Immunological Effect of Bee Venom on Chronic Diseases in Human

  2014cites this paper
• Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.

  2014cites this paper
• Interferon-α-2a

  2012cites this paper
• Treatment of hepatitis C virus infection after kidney transplantation.

  2012cites this paper
• Amantadine in non-responder patients with chronic hepatitis C: a randomized prospective study.

  2012cites this paper
• Treatment issues surrounding hepatitis C in renal transplantation: a review.

  2011cites this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cites this paper
• No beneficial effects of amantadine in treatment of chronic hepatitis C patients.

  2010cites this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cites this paper
• Ribavirin monotherapy for chronic hepatitis C.

  2009cites this paper
• Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence

  2008cites this paper
• Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C. A randomized, controlled pilot study.

  2007cites this paper
• Chronic hepatitis C and no response to antiviral therapy: A perpetual problem

  2007cites this paper
• Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-&agr; and ribavirin: results from a randomized, placebo-controlled, double-blind trial

  2007cites this paper
• WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

  2007cites this paper
• American Gastroenterological Association technical review on the management of hepatitis C.

  2006cites this paper
• Ribavirin monotherapy for chronic hepatitis C.

  2005cites this paper
• Depressivität bei Patienten mit chronischer Hepatitis C vor und während der Behandlung mit Alpha-Interferon und Ribavirin

  2005cites this paper
• Amantadine in treatment of chronic hepatitis C virus infection?

  2005influential citation
• Life-threatening purpura and vasculitis.

  2005cites this paper
• Ribavirin - dose and concentration in treatment of chronic hepatitis C infected patients

  2005cites this paper
• Hepatitis C virus kinetics during antiviral treatment

  2004influential citation
• Role of Amantadine and Other Adjuvant Therapies in the Treatment of Hepatitis C

  2004cites this paper
• Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.

  2004cites this paper
• Evaluation of amantadine in chronic hepatitis C: a meta-analysis.

  2004cites this paper
• Pegylated interferon-2 a and-2 b in combination with ribavirin in the treatment of chronic hepatitis C : a systematic review and economic evaluation

  2004cites this paper
• Novel combined approaches to hepatitis C therapies

  2003cites this paper
• Treatment of chronic hepatitis C in nonresponders to previous therapy

  2003cites this paper
• Meta‐analysis: combination therapy with interferon‐α 2a/2b and ribavirin for patients with chronic hepatitis C previously non‐responsive to interferon

  2002cites this paper
• Amantadine and interferon in the combined treatment of hepatitis C virus in elderly patients.

  2002cites this paper
• Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C.

  2002cites this paper
• Hepatitis C advances in antiviral therapy: What is accepted treatment now?

  2002cites this paper
• Ribavirin with or without alpha interferon for chronic hepatitis C.

  2002cites this paper
• Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie Charité, Campus Virchow-Klinikum (Direktor: Professor Dr. Bertram Wiedenmann)

  2002cites this paper
• Hepatitis C and the skin.

  2002cites this paper
• Tratamiento antivírico de la hepatitis crónica C en pacientes no respondedores al interferón

  2002cites this paper
• Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.

  2002cites this paper
• [Antiviral treatment of chronic hepatitis C in interferon nonresponders].

  2002cites this paper
• Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial.

  2001cites this paper
• Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon

  2001cites this paper
• Pilot study of interferon-α high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C

  2001cites this paper
• Current treatment strategies for chronic hepatitis B and C.

  2001cites this paper
• Hepatitis C virus replication is directly inhibited by IFN-α in a full-length binary expression system

  2001cites this paper
• [Chronic viral hepatitis C: current therapy and perspectives].

  2001cites this paper
• Therapy for chronic hepatitis C.

  2001cites this paper
• Hépatites chroniques virales C : actualités thérapeutiques

  2001cites this paper
• Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?

  2001cites this paper
• Editorial Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?

  2001cites this paper
• Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections

  2001cites this paper
• A new era of interferon treatment for chronic hepatitis C is coming

  2000cites this paper
• Retreatment of hepatitis C patients who do not respond to interferon: the search continues

  2000cites this paper
• Treatment of chronic hepatitis C with interferon in combination with other compounds.

  2000cites this paper
• Treatment options in patients with chronic hepatitis C.

  2000cites this paper
• Re: Khalili et al.— chronic hepatitis C treatment in interferon nonresponders

  2000cites this paper
• Randomized, double‐blind, placebo‐controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C

  2000cites this paper
• Treatment of Chronic Hepatitis C Virus Infection

  2000cites this paper
• Antiviral therapy of HBV- and HCV-induced liver cirrhosis.

  2000cites this paper
• HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin

  2000cites this paper
• What should we advise about adjunctive therapies, including herbal medicines, for hepatitis C?

  2000cites this paper
• Treatment of hepatitis C virus infection after renal transplantation: new insights.

  2000cites this paper
• Treatment Options in Patients with Chronic Hepatitis C

  2000cites this paper
• Retreatment of hepatitis C patients who do not respond to interferon: the search continues.

  2000cites this paper
• What should we advise about adjunctive therapies, including herbal medicines, for hepatitis C?

  2000cites this paper
• Options de traitement pour les patients atteints d’hépatite C chronique

  2000cites this paper
• [Antiviral therapy of hepatitis C].

  2000cites this paper
• Triple Antiviral Therapy as a New Option for Patients With Interferon Nonresponsive Chronic Hepatitis C

  2000cites this paper
• Antivirale Therapie der Hepatitis C*

  2000cites this paper
• Pathogenesis, diagnosis and management of hepatitis C.

  2000cites this paper
• Acalculous cholecystitis as an atypical presentation of dengue fever

  2000cites this paper
• Therapie chronischer viraler Hepatitiden

  1999cites this paper
• Therapie chronischer viraler Hepatitiden

  1999cites this paper
• Nonsteroidal anti‐inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation

  1999cites this paper
• [Therapy of chronic viral hepatitis].

  1999cites this paper
• Overview of interferon therapy for chronic hepatitis C.

  1999cites this paper
• Hepatitis C

  1999cites this paper
• Combination therapy for chronic hepatitis C.

  1999cites this paper
• Hepatitis C and HIV infection: biological, clinical, and therapeutic implications.

  1999cites this paper